ErbB receptors: from oncogenes to targeted cancer therapies
Hongtao Zhang(Chinese Academy of Sciences), Mark I. Greene, Jeffrey A. Drebin(Memorial Sloan Kettering Cancer Center), Geng Zhang(Hebei Medical University), Ramachandran Murali(The Wistar Institute), Qiang Wang(Cedars-Sinai Medical Center), Alan Berezov
Cited by 578
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
|Nature Communications|2015|484
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435